Discontinuation of eculizumab treatment in atypical hemolytic uremic syndrome: an update
- PMID: 26111906
- DOI: 10.1053/j.ajkd.2015.04.010
Discontinuation of eculizumab treatment in atypical hemolytic uremic syndrome: an update
Comment on
-
Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases.Am J Kidney Dis. 2014 Oct;64(4):633-7. doi: 10.1053/j.ajkd.2014.01.434. Epub 2014 Mar 19. Am J Kidney Dis. 2014. PMID: 24656451
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical